Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Are child safe ibuprofen options available?How much will cholesterol levels rise by skipping lipitor?Does alcohol consumption have any positive cognitive impacts?Note it's important to consult with a healthcare professional for accurate information regarding medications and their potential long term effects?What's the role of food in aspirin's stomach protection?
See the DrugPatentWatch profile for vascepa
Early Benefits of Vascepa: Short-term Effects Vascepa, a prescription fish-oil medication, is primarily used to treat high triglycerides in adults [1]. It contains a highly concentrated form of omega-3 fatty acid, eicosapentaenoic acid (EPA). Studies have shown that EPA, a key component of Vascepa, can reduce triglyceride levels and provide cardiovascular benefits in as little as 12 weeks [2]. Long-term Effects of Vascepa Therapy Clinical trials have demonstrated that long-term treatment with Vascepa can lead to sustained reductions in triglyceride levels, as well as a lower risk of cardiovascular events such as heart attacks and strokes [3]. A landmark trial published in 2019 showed that Vascepa reduced the risk of major adverse cardiovascular events by 25% over a 5-year period compared to a placebo [4]. When to Expect Results While individual results may vary, patients can typically expect to see the benefits of Vascepa within the first few weeks to months of treatment. Here's a general timeline for what patients can expect: * 1-4 weeks: Reduction in triglyceride levels, as well as some initial cardiovascular benefits * 12 weeks: Established reduction in triglyceride levels, as well as noticeable improvements in cardiovascular health * 5 years: Sustained reduction in triglyceride levels, as well as reduced risk of cardiovascular events Please consult with your healthcare provider for a personalized treatment plan and to discuss your individual results and expectations. Sources: [1] https://www.drugpatentwatch.com/drug/vascepa-ethyl-eicosapentaenoic-ethyl-ester/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341417/ [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541410/ [4] https://www.nejm.org/doi/full/10.1056/NEJMoa1801314
Other Questions About Vascepa :